Keyword "HYPERTENSIVE NEURORETINOPATHY" found in the following publications:

• CORRECTION OF HYPERTENSIVE RETINAL CHANGES IN RATS WITH SEMAX

  Background: Currently, there are no drugs for the specific treatment of hypertensive retinal changes. The main therapy is for ...

  Abstract | Full text (PDF)

• THE DEVELOPMENT OF HYPERTENSIVE NEURORETINOPATHY MODEL ON WISTAR RATS

  A model of hypertensive neuroretinopathy was developed on Wistar line rats with administration of non-selective NO-synthase blocker N-nitro-L-arginine methyl ester ...

  Abstract | Full text (PDF)

• PHARMACOLOGICAL CORRECTION OF MORPHOFUNCTIONAL RETINAL INJURY USING 11-AMINO ACID FRAGMENT OF DARBEPOETIN IN THE EXPERIMENT

  Introduction: The retinoprotective effect of the 11-amino acid fragment of darbepoetin PRK-002 on the models of hypertensive retinal angiopathy and ...

  Abstract | Full text (PDF)

• COMPARATIVE EVALUATION OF THE EFFECTIVENESS OF DMAE DERIVATIVE 7-16, CARBAMILATED DARBEPOETIN AND SUBSTANCE C7070 IN CORRECTION OF HYPERTENSIVE NEURORETINOPATHY IN RATS

  Background: Increasing the effectiveness of drug therapy for hyperintensive neuroretinopathy is one of the important tasks of pharmacology and ophthalmology. ...

  Abstract | Full text (PDF)